ARTICLE | Clinical News
GenESA system: Completed enrollment of 700 patients in Phase III trials
June 21, 1993 7:00 AM UTC
Gensia Inc. (GNSA) Product: GenESA system to pharmacologically stress the heart Indication: Diagnosing coronary artery disease in conjuction with electrocardiography, echocardiography and radionuclid...